Share on StockTwits

Mead Johnson Nutrition CO (NYSE:MJN) CFO Peter G. Leemputte unloaded 76,212 shares of Mead Johnson Nutrition CO stock on the open market in a transaction dated Friday, August 8th. The shares were sold at an average price of $91.56, for a total value of $6,977,970.72. Following the completion of the sale, the chief financial officer now directly owns 33,163 shares of the company’s stock, valued at approximately $3,036,404. The transaction was disclosed in a document filed with the SEC, which is available at this link.

MJN has been the subject of a number of recent research reports. Analysts at BMO Capital Markets raised their price target on shares of Mead Johnson Nutrition CO from $82.00 to $92.00 in a research note on Wednesday, July 23rd. They now have a “market perform” rating on the stock. Separately, analysts at Citigroup Inc. reiterated a “buy” rating on shares of Mead Johnson Nutrition CO in a research note on Wednesday, July 23rd. They now have a $109.00 price target on the stock, up previously from $105.00. Finally, analysts at Credit Suisse reiterated an “outperform” rating on shares of Mead Johnson Nutrition CO in a research note on Wednesday, July 23rd. They now have a $105.00 price target on the stock, up previously from $97.00. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Mead Johnson Nutrition CO presently has a consensus rating of “Buy” and a consensus target price of $99.78.

Mead Johnson Nutrition CO (NYSE:MJN) traded up 1.10% on Monday, hitting $94.13. 362,367 shares of the company’s stock traded hands. Mead Johnson Nutrition CO has a 52-week low of $73.23 and a 52-week high of $98.36. The stock’s 50-day moving average is $93.24 and its 200-day moving average is $86.18. The company has a market cap of $19.030 billion and a price-to-earnings ratio of 28.57.

Mead Johnson Nutrition CO (NYSE:MJN) last issued its quarterly earnings data on Tuesday, July 22nd. The company reported $0.88 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.90 by $0.02. The company had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same quarter in the previous year, the company posted $0.84 earnings per share. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. Analysts expect that Mead Johnson Nutrition CO will post $3.72 EPS for the current fiscal year.

Mead Johnson Nutrition Company (NYSE:MJN) is a global pediatric nutrition company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.